Consulting
Alun, a seasoned statistical leader in the pharmaceutical industry, brings a unique blend of experience and expertise to your consultancy issues.
Meeting specific needs
His comprehensive understanding of all aspects of drug development, coupled with his adeptness in navigating regulatory authorities and ethics committees, sets him apart from other statistical consultants.
Alun's statistical consultation services are tailored to meet the specific needs of early clinical development and the creation of innovative development plans and clinical trials. His mastery in dose-finding and adaptive designs translates into practical solutions that can accelerate your drug development process.
Alun's approach to leadership and learning is rooted in the belief that every challenge is an opportunity for growth. He sees 'FAIL' not as a negative outcome, but as an acronym for 'FIRST ATTEMPT IN LEARNING', a testament to his resilience and commitment to continuous improvement.
For a list of Alun’s publications please look at his Google Scholar page by clicking the button below: